Literature DB >> 22513237

Erythrocyte sedimentation rate - possible role in determining the existence of the low grade inflammation in Irritable Bowel Syndrome patients.

Goran Hauser1, Mladenka Tkalcic, Sanda Pletikosic, Nina Grabar, Davor Stimac.   

Abstract

Irritable Bowel Syndrome (IBS), the most prevalent functional gastrointestinal disorder, is best described by the presence of recurrent symptoms of abdominal pain, diarrhea and/or constipation. It has been thought that IBS is stress-related disorder with no known structural abnormalities, e.g. infectious, biochemical or metabolic causes. But, recent evidence suggests that inflammation within the gastrointestinal tract may be of great importance in the pathogenesis of IBS. Our question is could the conventional and widely available general biological markers of inflammation such as erythrocyte sedimentation rate (ESR) be indicator of microscopic inflammatory process in some IBS patients? We hypothesize that mild inflammation in IBS patients could be detected by meaning of a sensitive but cheap and ubiquitous test - ESR. Furthermore we assume that ESR would be related with the disease severity index and decreased general and disease-specific health-related quality of life (HRQoL). A pilot study has been conducted with 86 outpatients (65% female) with IBS, average age 47.76 (SD=13.68). The preliminary results were partly in favor of our hypothesis. They showed that IBS patients with higher ESR expressed lower disease-specific HRQoL (e.g. they expressed more bowel symptoms, social and emotional disturbances related to disease). No significant correlations were found between ESR and the disease severity as well as general HRQoL.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22513237     DOI: 10.1016/j.mehy.2012.03.020

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  8 in total

Review 1.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

Review 2.  PD-1/PD-L1 expression in pancreatic cancer and its implication in novel therapies.

Authors:  Adrian Mucileanu; Romeo Chira; Petru Adrian Mircea
Journal:  Med Pharm Rep       Date:  2021-10-30

Review 3.  Diagnosis of Irritable Bowel Syndrome: Role of Potential Biomarkers.

Authors:  Ivana Plavšić; Goran Hauser; Mladenka Tkalčić; Sanda Pletikosić; Nermin Salkić
Journal:  Gastroenterol Res Pract       Date:  2015-06-11       Impact factor: 2.260

4.  ESR rate can be a marker for coronary artery disease.

Authors:  Tasnim Eghbal Eftekhaari
Journal:  Vasc Health Risk Manag       Date:  2012-12-18

5.  Erythrocyte Sedimentation Rate Measurement Using as a Rapid Alternative to the Westergren Method.

Authors:  Reza Hashemi; Alireza Majidi; Hassan Motamed; Afshin Amini; Fares Najari; Ali Tabatabaey
Journal:  Emerg (Tehran)       Date:  2015

Review 6.  Serum biomarkers for irritable bowel syndrome.

Authors:  Alexandra Chira; Dan Lucian Dumitrascu
Journal:  Clujul Med       Date:  2015-07-01

Review 7.  Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking.

Authors:  Ioana-Miruna Balmus; Ovidiu Ilie-Dumitru; Alin Ciobica; Roxana-Oana Cojocariu; Carol Stanciu; Anca Trifan; Mirela Cimpeanu; Cristian Cimpeanu; Lucian Gorgan
Journal:  Medicina (Kaunas)       Date:  2020-01-19       Impact factor: 2.430

8.  Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.

Authors:  Xiang Tan; Xing-Jie Zhao; Jun-Xiang Li; Chun-E Xie; Wen-Jing Pei; Lei Shi; Fu-Shun Kou; Ya-Li Yuan; Xiao-Xuan Xue
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.